Gene · 57142
Papers2,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Adipose-Derived Stem Cells Reduce Cellular Damage after Experimental Spinal Cord Injury in Rats. | Biomedicines | 2023 | 37239065 | PubTator, text mining | PubMed |
| A Novel Longitudinal Phenotype-Genotype Association Study Based on Deep Feature Extraction and Hypergraph Models for Alzheimer's Disease. | Biomolecules | 2023 | 37238598 | PubTator, text mining | PubMed |
| Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families. | J Cell Sci | 2023 | 37232246 | PubTator, text mining | PubMed |
| Heteromeric clusters of ubiquitinated ER-shaping proteins drive ER-phagy. | Nature | 2023 | 37225994 | PubTator, text mining | PubMed |
| Association of RTN4 indel polymorphisms with the risk of tumorigenesis in the Chinese Han population. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37224043 | PubTator, text mining | PubMed |
| Collagen for neural tissue engineering: Materials, strategies, and challenges. | Mater Today Bio | 2023 | 37197743 | PubTator, text mining | PubMed |
| Identification of Sex-Specific Genetic Polymorphisms Associated with Asthma in Middle-Aged and Older Canadian Adults: An Analysis of CLSA Data. | J Asthma Allergy | 2023 | 37197194 | PubTator, text mining | PubMed |
| Multiomics analysis of adaptation to repeated DNA damage in prostate cancer cells. | Epigenetics | 2023 | 37196186 | PubTator, text mining | PubMed |
| Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications. | Oncogene | 2023 | 37193819 | PubTator, text mining | PubMed |
| The neurovascular unit in healthy and injured spinal cord. | J Cereb Blood Flow Metab | 2023 | 37190756 | PubTator, text mining | PubMed |
| Role of non-coding variants in cardiovascular disease. | J Cell Mol Med | 2023 | 37183561 | PubTator, text mining | PubMed |
| High expression of RTN4IP1 predicts adverse prognosis for patients with breast cancer. | Transl Cancer Res | 2023 | 37180657 | PubTator, text mining | PubMed |
| From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID. | Int J Mol Sci | 2023 | 37175995 | PubTator, text mining | PubMed |
| Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury. | Int J Mol Sci | 2023 | 37175842 | PubTator, text mining | PubMed |
| Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation. | Redox Biol | 2023 | 37150151 | PubTator, text mining | PubMed |
| Identification of biomarkers for glycaemic deterioration in type 2 diabetes. | Nat Commun | 2023 | 37137910 | PubTator, text mining | PubMed |
| G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. | Signal Transduct Target Ther | 2023 | 37137892 | PubTator, text mining | PubMed |
| Electrophysiological underpinnings of dysfunctional inhibitory control in adults with attention-deficit/hyperactivity disorder: evidence for reduced NoGo anteriorization. | J Neural Transm (Vienna) | 2023 | 37131048 | PubTator, text mining | PubMed |
| Renal dysfunction, malignant neoplasms, atherosclerotic cardiovascular diseases, and sarcopenia as key outcomes observed in a three-year follow-up study using the Werner Syndrome Registry. | Aging (Albany NY) | 2023 | 37130431 | PubTator, text mining | PubMed |
| The 4-Hydroxynonenal-Protein Adducts and Their Biological Relevance: Are Some Proteins Preferred Targets? | Antioxidants (Basel) | 2023 | 37107229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57142/papers?page=12